E Fund Management Co., Ltd. - VERVE THERAPEUTICS INC ownership

VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 93 filers reported holding VERVE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
E Fund Management Co., Ltd. ownership history of VERVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$191
-21.1%
14,397
+11.6%
0.02%
-21.1%
Q2 2023$242
+12.6%
12,898
-13.6%
0.02%
+18.8%
Q1 2023$215
-43.1%
14,936
-23.5%
0.02%
-48.4%
Q4 2022$378
-99.9%
19,523
+58.8%
0.03%
-20.5%
Q3 2022$422,000
+99.1%
12,292
+32.4%
0.04%
+457.1%
Q1 2022$212,0009,2820.01%
Other shareholders
VERVE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 2,508,809$57,251,0008.18%
Alphabet Inc. 10,974,011$250,427,0008.12%
M28 Capital Management LP 178,500$4,073,0003.74%
Casdin Capital, LLC 3,138,167$71,613,0003.21%
Ally Bridge Group (NY) LLC 105,360$2,404,0001.78%
Redmile Group, LLC 1,835,328$41,882,0001.31%
Cormorant Asset Management, LP 700,710$15,990,0001.23%
Novo Holdings A/S 750,000$17,115,0000.90%
Artal Group S.A. 400,000$9,128,0000.38%
PFM Health Sciences, LP 369,765$8,438,0000.32%
View complete list of VERVE THERAPEUTICS INC shareholders